364 related articles for article (PubMed ID: 19924111)
1. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
[TBL] [Abstract][Full Text] [Related]
2. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
[TBL] [Abstract][Full Text] [Related]
3. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Laje G; Perlis RH; Rush AJ; McMahon FJ
Psychiatr Serv; 2009 Nov; 60(11):1446-57. PubMed ID: 19880459
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence variants of the FKBP5 gene are associated with unipolar depression.
Zobel A; Schuhmacher A; Jessen F; Höfels S; von Widdern O; Metten M; Pfeiffer U; Hanses C; Becker T; Rietschel M; Scheef L; Block W; Schild HH; Maier W; Schwab SG
Int J Neuropsychopharmacol; 2010 Jun; 13(5):649-60. PubMed ID: 20047716
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.
Poweleit EA; Aldrich SL; Martin LJ; Hahn D; Strawn JR; Ramsey LB
J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):348-361. PubMed ID: 31066578
[No Abstract] [Full Text] [Related]
7. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
[TBL] [Abstract][Full Text] [Related]
8. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
[TBL] [Abstract][Full Text] [Related]
9. The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.
Lekman M; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ; Paddock S
Biol Psychiatry; 2008 Jun; 63(12):1103-10. PubMed ID: 18191112
[TBL] [Abstract][Full Text] [Related]
10. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T; Fabbri C; Bentini F; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
[TBL] [Abstract][Full Text] [Related]
12. HTR2A gene variation is involved in antidepressant treatment response.
Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
[TBL] [Abstract][Full Text] [Related]
13. Somatization in major depression--clinical features and genetic associations.
Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
[TBL] [Abstract][Full Text] [Related]
15. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.
Peters EJ; Slager SL; Jenkins GD; Reinalda MS; Garriock HA; Shyn SI; Kraft JB; McGrath PJ; Hamilton SP
Pharmacogenet Genomics; 2009 Jan; 19(1):1-10. PubMed ID: 19077664
[TBL] [Abstract][Full Text] [Related]
16. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
17. Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.
Shinozaki G; Jowsey S; Amer H; Biernacka J; Colby C; Walker D; Black J; Rundell J; Stegall M; Mrazek DA
Depress Anxiety; 2011 Dec; 28(12):1111-8. PubMed ID: 22134958
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 34 candidate genes in bupropion and placebo remission.
Tiwari AK; Zai CC; Sajeev G; Arenovich T; Müller DJ; Kennedy JL
Int J Neuropsychopharmacol; 2013 May; 16(4):771-81. PubMed ID: 22947179
[TBL] [Abstract][Full Text] [Related]
19. FKBP5 polymorphisms and antidepressant response in geriatric depression.
Sarginson JE; Lazzeroni LC; Ryan HS; Schatzberg AF; Murphy GM
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):554-560. PubMed ID: 19676097
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
Perlis RH; Moorjani P; Fagerness J; Purcell S; Trivedi MH; Fava M; Rush AJ; Smoller JW
Neuropsychopharmacology; 2008 Nov; 33(12):2810-9. PubMed ID: 18288090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
